Before you sell to, join or invest in Idaptiq Trials Inc.
MentionFox check on Idaptiq Trials Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/idaptiq-trials-inc-form-d-001520
Check Idaptiq Trials Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Idaptiq Trials Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Idaptiq Trials Inc. filed a Form D with the Securities and Exchange Commission on 2026-11-02.
Idaptiq Trials Inc. filed a Form D notice of an exempt securities offering with the SEC on November 2, 2026. The filing reports $2.79M sold. Its industry group is Other Technology. It names Sandra Brine (Executive Officer, Director, Promoter), Nathaniel Fox (Executive Officer) (SEC Form D, November 2, 2026).
Selling to Idaptiq Trials Inc.? See who runs it and how to reach them, plus this week's 43 other newly funded companies.
Is this your company?
Sell to companies like Idaptiq Trials Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-11-02 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Idaptiq Trials Inc.
Free to see. No signup.
More on the people and the money behind Idaptiq Trials Inc., from the filings we hold.
Other Technology raises by companies based in Michigan, filed within 90 days of this one, largest first.
Get an email when Idaptiq Trials Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Idaptiq Trials Inc. raises, hires or launches. No email unless you switch it on.
Watch Idaptiq Trials Inc. →Get the full cited report on Idaptiq Trials Inc.
What the filing shows about Idaptiq Trials Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Idaptiq Trials Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Idaptiq Trials Inc.'s address as 15051 US Highway 23 S, Presque Isle, MI 49777.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Idaptiq Trials Inc. is a registered filer with the SEC (CIK 2161388) and has filed since 2026-11-02. 1 filing is on record, the latest on 2026-11-02.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Idaptiq Trials Inc.'s Form D of 2026-11-02 names Sandra Brine and Nathaniel Fox as its officers, directors or promoters.
Its new offerings report $2.79M sold across 1 offering, as its own filings state.
Trailing twelve months. 3839 filings in Other Technology, totalled by week. The dot is this raise, $2.79M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Sandra Brine is named as Executive Officer and Director and Promoter on the Form D that Idaptiq Trials Inc. filed with the SEC on 2 November 2026, one of 2 people that filing names.
Nathaniel Fox is named as Executive Officer on the Form D that Idaptiq Trials Inc. filed with the SEC on 2 November 2026, one of 2 people that filing names.
2 people named on the filing — 2 holding an executive role.
Named as of the 2026-11-02 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Idaptiq Trials Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Idaptiq Trials Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Idaptiq Trials Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Idaptiq Trials Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Idaptiq Trials Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Idaptiq Trials Inc.. With no account yet, you sign up free and land on the result.
On these lists: The rest of the US raises, week of 2026-11-02 · AI and software raises, week of 2026-11-02
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/idaptiq-trials-inc-form-d-001520